Correction to: Chronomedicine and type 2 diabetes: shining some light on melatonin

Andrew C Forrestel; Susanne U Miedlich; Michael Yurcheshen; Steven D Wittlin; Michael T Sellix

doi:10.1007/s00125-018-4577-3

Correction to: Chronomedicine and type 2 diabetes: shining some light on melatonin

Diabetologia. 2018 May;61(5):1237. doi: 10.1007/s00125-018-4577-3.

Authors

Andrew C Forrestel¹, Susanne U Miedlich¹, Michael Yurcheshen², Steven D Wittlin¹, Michael T Sellix³

Affiliations

¹ Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 693, Rochester, NY, 14642, USA.
² UR Medicine Sleep Center, Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
³ Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 693, Rochester, NY, 14642, USA. Michael_Sellix@urmc.rochester.edu.

PMID: 29470590
DOI: 10.1007/s00125-018-4577-3

Abstract

The authors have been made aware that the following sentence is incorrect: 'Like IIK7, both ramelteon and tasimelteon have a greater affinity for the MT2 receptor [162].'

Publication types

Published Erratum